Logo image
Isolated MLH1 Loss by Immunohistochemistry Because of Benign Germline
Journal article   Open access   Peer reviewed

Isolated MLH1 Loss by Immunohistochemistry Because of Benign Germline

Dustin E Bosch, Matthew M Yeh, Stephen J Salipante, Angela Jacobson, Stacey A Cohen, Eric Q Konnick and Vera A Paulson
JCO precision oncology, Vol.6, e2200227
08/31/2022
DOI: 10.1200/PO.22.00227
PMCID: PMC9489174
PMID: 36044719
url
https://doi.org/10.1200/PO.22.00227View
Published (Version of record) Open Access

Abstract

Mismatch repair (MMR) immunohistochemistry (IHC) is frequently used to inform prognosis, select (immuno-)therapy, and identify patients for heritable cancer syndrome testing. However, false-negative and false-positive MMR IHC interpretations have been described.Following identification of discordant MMR IHC and DNA-based microsatellite instability testing in a patient with colorectal carcinoma, we retrospectively reviewed institutional archives to identify patient samples with similar discrepancies.We report a patient with metastatic colorectal carcinoma who initially received immunotherapy on the basis of apparent isolated loss of MLH1 by IHC; notably,This study confirms that rare germline polymorphisms can result in incorrect IHC results, potentially affecting selection of optimal therapy and the decision to pursue germline testing. This case further highlights the need for expert molecular pathologic review and communication between clinical and molecular oncology teams.
Immunohistochemistry MutL Protein Homolog 1 Microsatellite Instability Humans Female Colorectal Neoplasms Retrospective Studies Endometrial Neoplasms Germ Cells

Details

Metrics

Logo image